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disease? Is selection down to differences in which cell-types are initially
infected or which cell-types are targeted and eliminated leading to dif-
ferences in maintenance of immunity and better viral control? If so,
this would be via a phenotype restricted by the Env (gp120/gp41) prop-
erties of the virus inﬂuencingwhich cell-types are preferentially infected.
Theremust be some strong biological barrier thatmaintains this block toIn this issue of EBioMedicine, Venner and co-authors [1] expand the
observation that variant subtypes of HIV-1 are highly divergent in
terms of biological phenotypes. This study goes further to link this di-
versity to disease course and outcome. Through studying a natural his-
tory cohort of HIV-1 infected Ugandan and Zimbabwean women from
time of infection and in some cases through to 9 years of follow up the
authors conclude that those infected with subtype C viruses have
lower rates of CD4 T-cell decline and progress slower in disease than
those infected with either subtype A or D viruses. Through comparing
viral isolates for cell-entry, PBMC replication and cell-to-cell transmis-
sion they demonstrate that subtype C viruses are generally less ﬁt
than other subtypes. The strength to this report is the ﬁnding that
these differences in viral phenotype match natural clinical progression.
The observation that HIV-1 subtype C viruses are in general less ﬁt for
viral ﬁtness, both in vitro and in vivo, than other subtypes raises interest-
ing questions regarding the basic virology of HIV-1 and constraints on
viral evolution. It has been well documented that HIV-1 subtype C is
the most prevalent subtype within certain regions of Africa, namely
Ethiopia and South Africa, even when other subtypes reside within the
population, indicating a transmission ﬁtness that is not associated with
replication capacity. This can be down to numerous genetic differences
within the host population and which have all been linked to control of
viral replication, including HLA types, chemokine and/or chemokine re-
ceptor haplotypes as well as cytokine genes which relate to enhance-
ment or control of viral replication [2]. The present study, although
comparing individuals from two different countries (Uganda and
Zimbabwe), goes some way to highlight that these populations do not
differ in relation to such genes. The ﬁndings demonstrate major differ-
ences in the biological properties between the HIV-1 subtype isolates
which are preserved over time. Why should subtypes maintain strictly
delineated phenotypes, especially given the high evolution capabilities
of the virus? Why do subtypes not converge towards being the ﬁttestom.2016.10.014.
. This is an open access article underin terms of transmission as well as maintaining high viral loads during
subtype convergence; currently unknown but essential to decipher.
Subtype C viruses rarely switch co-receptor phenotype and general-
ly maintain solo CCR5 usage, whereas other subtypes and especially D,
frequently switch co-receptor to using CXCR4 [3]. There seems to be
an inherent molecular component to the HIV-1 Env protein that
maintains a conﬁguration that associates with entry efﬁciency and rep-
lication ﬁtness that can manifest in maintenance of properties such as
co-receptor usage. The major regions of the gp120 protein directing
co-receptor usage are the variable loops and where molecular pressure
maintaining a speciﬁc phenotype resides [4]. The gp120 amino acid pro-
ﬁle of viruses that undergo transmission and those emerging following
infection and later in disease have been well characterised [5,6]. It has
recently been identiﬁed that the amino acid length of the V1V2 and
V4V5 regions are inversely correlated at time of infection and lost fol-
lowing seroconversion [7]. Env-induced antibody responses likely con-
tribute to the maintenance or selection of these properties in vivo but
why these should be different amongst individuals infectedwith variant
subtypes is not known. It is established that gp120 sequences can be
linked to antibody selection, mainly in terms of V1V2 and V3 diversity,
especially relating to N-linked glycosylation proﬁles [8]. Antibody selec-
tion is typically absent at time of transmission thereby allowing for
potential selection or reversion of transmitted viruses. Structural con-
straints within the gp120 protein likely associate with Env function,
which may differ between subtypes and can be inﬂuenced through an-
tibody selection. It has been proposed that a smaller V1V2 region with
less glycosylation can enhance HIV-1 fusion for subtype C viruses on
both CD4 T-cells andmacrophage [9]. Amore recent study has indicated
that genetic variations within the subtype C gp41molecule can impede
HIV-1 entry and replicationwithin CD4 T-cells andmodulate cell-to-cell
transmission but not in macrophages [10]. The results are interpreted
that subtype speciﬁc Env incorporation within viral membranes can
be subtype speciﬁc. Therefore, does a complex speciﬁc interaction
exist not just between the regions of the gp120 protein but also be-
tween the gp120 and gp41 molecules?
Collectively, there are major restrictions within Env biological prop-
erties between the HIV-1 subtypes which lead to variation in HIV-1the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
28 W.A. Paxton / EBioMedicine 13 (2016) 27–28transmission rates andwhich can inﬂuence disease. Themaintenance of
such properties indicates that the molecular constraints are preserved
and provide some promise that not all Env targeted therapies or vac-
cines can be readily escaped. Understanding these constraints will likely
pinpointwhere therapy and vaccine strategies need to be directed, albe-
it in a subtype aswell as regional speciﬁcmanner. Similarly, antiretrovi-
ral treatment requirements may differ regionally dependent on the
circulatory types.
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